HBM Holdings FY26 H1 profit falls 11.16% to US$ 64.85 million; revenue rises 20.9% to US$ 122.49 million

• HBM Holdings posted revenue of US$122.49 million for the six months ended June 30, 2026, up 20.9% year on year.
• Profit for the period fell 11.1% to US$64.85 million; basic earnings per share slipped to US$0.08 from US$0.09.
• Research and development costs more than doubled to US$29.6 million; administrative expenses more than doubled to US$16.67 million.
• Cash and cash equivalents declined to US$359.16 million at June 30, 2026 from US$403.06 million at Dec. 31, 2025.
• Company highlighted a US$20.2 million jury damages award in a U.S. patent case against Amgen and Teneobio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303377), on August 27, 2026, and is solely responsible for the information contained therein.